Biomarkers of Infection-Associated Cancers (R21)
The summary for the Biomarkers of Infection-Associated Cancers (R21) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Biomarkers of Infection-Associated Cancers (R21): -Purpose. . This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR), of the National Institutes of Health (NIH), encourages the submission of Research Project Grant (R01) applications from institutions and organizations that propose to identify biomarkers for cancers where the etiology of the disease is attributed to infectious agents. -Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-156, that solicits applications under the NIH Research Project Grant (R01) mechanism. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications; therefore, the anticipated number of awards is not known. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
| Federal Grant Title: | Biomarkers of Infection-Associated Cancers (R21) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-08-157 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.12193.393 |
| CFDA Descriptions: | Oral Diseases and Disorders Research 93.393 Cancer Cause and Prevention Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | May 07, 2011 |
| Posted Date: | Apr 22, 2008 |
| Creation Date: | Apr 22, 2008 |
| Archive Date: | Dec 05, 2008 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $200,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.394 -- Cancer Detection and Diagnosis Research |
- Applicants Eligible for this Grant
- Small businesses State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster